GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
Healio12d
Subcutaneous adjuvant regimen for breast cancer reduces ‘time toxicity’ of treatment
Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...
The American Journal of Managed Care7d
With Sub-Q Immunotherapy Coming, “Patient Preference Has to Be the Key”
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
Calif. startup is selling injectable cannabis. The FDA isn't happy.
A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...
EMS110d
FDA approves clot-dissolving agent for treatment of acute ischemic stroke
TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...
Risk of leaks, chemo drug spills prompt CancerCare Manitoba to stop using some IV pump equipment: memo
Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject ...
Devdiscourse3d
Mild Reactions to IV Glucose in Sangrur Prompt Stock Withdrawal
Fifteen patients in Sangrur experienced mild reactions after receiving intravenous glucose at the civil hospital. Authorities withdrew the affected batch. AAP MLA Narinder Kaur Bharaj and Punjab ...